Geraniol is an attractive natural monoterpene with significant
industrial and commercial value in the fields of pharmaceuticals,
condiments, cosmetics, and bioenergy. The biosynthesis of monoterpenes
suffers from the availability of key intermediates and enzyme-to-substrate
accessibility. Here, we addressed these challenges in Candida glycerinogenes by a plasma membrane-anchoring
strategy and achieved sustainable biosynthesis of geraniol using bagasse
hydrolysate as substrate. On this basis, a remarkable 2.4-fold improvement
in geraniol titer was achieved by combining spatial and temporal modulation
strategies. In addition, enhanced geraniol transport and modulation
of membrane lipid-associated metabolism effectively promoted the exocytosis
of toxic monoterpenes, significantly improved the resistance of the
engineered strain to monoterpenes and improved the growth of the strains,
resulting in geraniol yield up to 1207.4 mg L–1 at
shake flask level. Finally, 1835.2 mg L–1 geraniol
was obtained in a 5 L bioreactor using undetoxified bagasse hydrolysate.
Overall, our study has provided valuable insights into the plasma
membrane engineering of C. glycerinogenes for the sustainable and green production of valuable compounds